We are a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid-based (HOCl) therapeutics designed to prevent and treat infection in invasive applications. Our lead drug candidate, RUT58-60, is a broad spectrum anti-infective that we are developing for the prevention and treatment of infection in surgical and trauma procedures. We are focusing RUT58-60 for use initially in abdominal surgery due to the large addressable market, high rate of post-surgical infection associated with abdominal surgery, the high-impact opportunity that abdominal surgery offers us in the clinical trial setting to expose multiple internal organs to RUT58-60 at one time, and feedback from surgeons identifying post-surgical infection in abdominal surgery (relative to other surgeries) as a significant unmet medical need.
View Top Employees from Ruthigen, Inc.Website | http://www.ruthigen.com/ |
Ticker | NASDAQ:RTGN |
Revenue | $17000 |
Funding | $21.8 million |
Employees | View employees |
Founded | 2013 |
Address | 2455 Bennett Valley Rd, Ste C116, Santa Rosa, California 95404, US |
Phone | (707) 525-9900 |
Technologies |
JavaScript,
HTML,
PHP
+6 more
(view full list)
|
Industry | Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Health Care, Drug Manufacturing & Research |
SIC | SIC Code 599 Companies, SIC Code 59 Companies |
NAICS | NAICS Code 443 Companies, NAICS Code 44 Companies |
Looking for a particular Ruthigen, Inc. employee's phone or email?
The Ruthigen, Inc. annual revenue was $17000 in 2023.
Ruthigen, Inc. is based in Santa Rosa, California.
The NAICS codes for Ruthigen, Inc. are [443, 44].
The SIC codes for Ruthigen, Inc. are [599, 59].